Page 118 - FINAL PROGRAM

WEDNESDAY, 6 JULY 2016
14:00 - 15:15 Hall 5 A
Session 71: The compromised ovary
14:00 O-277 14:15 O-278 14:30 O-279
14:45 O-280
15:00 O-281
The effect of GV1001 and Bevacizumab combination therapy on follicle loss of ovary
M. Kim (Korea, South)
Novel microRNAs (miRNA) as Biomarkers for Toxic Insult in the Ovary
H. Furlong (Canada)
IImpact of environmental endocrine disruptor’s exposure in controlled ovarian stimulation outcome in egg donors
F. Dominguez (Spain)
Random-start ovarian stimulation in patients without cancer: comparison between conventional-start and random-start in different ovarian reserve
H. Matsubayashi (Japan)
Estimation of ovarian response with changing gonadotropin doses: a study of 14,805 women with repeated stimulation cycles
Z. Veleva (Finland)
114